FOLH1 rs55729124: Metabolic QTL and Endurance Insights
The genetic variant rs55729124 is an intronic single nucleotide polymorphism located in the FOLH1 gene on chromosome 11. Scientific research has linked this variant to circulating levels of the neuropeptide metabolite N-acetyl-aspartyl-glutamate (NAAG), functioning as a metabolite quantitative trait locus (mQTL). Although preliminary studies connect this biochemical pathway with metabolic profiles in elite endurance athletes, overall clinical and fitness evidence remains limited.
What each genotype means
Typical NAAG breakdown baseline
You carry two copies of the common C allele for rs55729124 in the FOLH1 gene. Research indicates this genotype is associated with standard baseline levels of the neuropeptide N-acetyl-aspartyl-glutamate (NAAG) and typical enzymatic activity of glutamate carboxypeptidase II. Because current evidence connecting this marker to athletic aerobic performance is limited to small cohort studies, this genotype reflects a standard physiological baseline rather than a performance deficit.
Carried by approximately 70% to 75% of individuals of European ancestry and is the predominant genotype across global populations.
Enhanced NAAG metabolism
You carry one copy of the minor T allele for rs55729124 in the FOLH1 gene. In metabolomic and fitness studies, this allele has been statistically associated with reduced circulating NAAG levels, which may indicate faster enzymatic conversion into NAA and glutamate during aerobic conditioning. However, scientific evidence linking this metabolic effect to tangible athletic endurance is currently preliminary and limited.
Carried by approximately 25% to 26% of individuals of European ancestry; observed at lower frequencies in other global ancestries.
Significantly enhanced NAAG metabolism
You carry two copies of the minor T allele for rs55729124 in the FOLH1 gene. This genotype exhibits the strongest association with decreased NAAG levels, consistent with augmented FOLH1-mediated catalytic activity. While hypothesized to interact with exercise adaptation and neuronal metabolic pathways, overall evidence establishing an impact on athletic endurance traits remains preliminary.
Carried by approximately 2% to 3% of individuals of European ancestry and is rare across most other ancestral populations.
Genetic Location and Variant Details
The single nucleotide polymorphism designated rs55729124 is positioned within an non-coding intronic region of the FOLH1 gene located on the short arm of chromosome 11. Because it does not alter the protein coding sequence directly, it functions primarily as a regulatory or proxy marker rather than altering amino acid composition. In genomic databases such as dbSNP, rs55729124 represents a single base substitution involving thymine and cytosine alleles. Intronic variants of this type frequently exert their influence through subtle modifications in gene transcription efficiency, alternative splicing regulation, or by existing in strong linkage disequilibrium with other functional genetic markers nearby. Although not classified as a monogenic disease mutation in clinical databases like ClinVar, rs55729124 serves as an informative genomic locus in metabolomic and physiological association studies.
The Biological Role of the FOLH1 Gene
The FOLH1 gene encodes folate hydrolase 1, also widely recognized in biochemical literature as glutamate carboxypeptidase II (GCPII) or prostate-specific membrane antigen (PSMA). This type II transmembrane zinc metallopeptidase acts enzymatically to cleave terminal glutamate residues from physiological substrates. In the human nervous system and peripheral tissues, GCPII is responsible for hydrolyzing the abundant neuropeptide N-acetyl-aspartyl-glutamate (NAAG) into N-acetylaspartate (NAA) and free glutamate. Through this specific enzymatic reaction, FOLH1 modulates excitatory neurotransmission, glutamate signaling, and localized cellular nutrient metabolism. Beyond the nervous system, FOLH1 plays functional roles in dietary folate absorption across the intestinal brush border and nutrient utilization in multiple tissue compartments, making its regulatory efficiency an important node in human intermediary metabolism.
Metabolic and Athletic Research Findings
Published metabolic genome-wide association studies (mGWAS), notably investigations in elite athletic cohorts, identified rs55729124 as a sentinel locus for NAAG concentrations. In these studies, carrying the minor allele was strongly associated with reduced circulating NAAG levels, likely reflecting altered enzymatic breakdown of NAAG into NAA and glutamate. In exercise physiology, elevations in tissue NAA have been investigated for roles in neural adaptation, cellular energy maintenance, and cognitive performance under aerobic stress. However, the scientific evidence connecting rs55729124 directly to physical performance phenotypes remains limited. Most available data stem from targeted cohorts of elite athletes compared against sedentary controls, meaning findings represent statistical metabolite associations rather than proven deterministic drivers of VO2 max or physical endurance.
Population Distribution and Genetic Context
The allele frequencies of rs55729124 vary noticeably across continental populations cataloged in human reference repositories such as gnomAD. In European-ancestry reference cohorts, the minor allele frequency is observed at approximately 15 percent (0.15), meaning a substantial fraction of individuals carry at least one copy of the variant allele. In contrast, athletic discovery cohorts have reported lower minor allele frequencies around 6 percent depending on the specific multi-ethnic recruitment criteria and sport categories analyzed. Because minor allele distributions can diverge between populations due to genetic drift and demographic history, association scores from European cohorts cannot be uniformly extrapolated to other ancestral backgrounds without direct local replication.
Translating Research to Daily Life
Discovering an individual genotype at rs55729124 provides an educational window into personal metabolic diversity, but it does not serve as a diagnostic tool or a predictive measure of athletic achievement. Elite performance and aerobic capacity are complex polygenic traits governed by thousands of interacting genetic loci, rigorous training, nutrition, recovery, and environment. Having a genotype linked to lower NAAG levels does not automatically confer superior stamina, nor does an alternative genotype limit cardiovascular adaptation to exercise. Consumers should treat this data as an emerging biological nuance of intermediary metabolism rather than a reason to initiate specialized supplementation or change personal fitness goals without guidance from certified training or medical professionals.
How common is this variant?
The minor allele frequency for rs55729124 is approximately 0.15 (15%) in general European populations according to genomic reference repositories, with lower frequencies around 0.06 reported in specific international athletic cohorts.
Frequently asked questions
Does my rs55729124 genotype predict whether I am a natural endurance athlete?
No, rs55729124 does not determine athletic capacity. While researchers identified it as a metabolic quantitative trait locus associated with neuropeptide breakdown in elite cohorts, aerobic performance depends on thousands of genetic variants alongside training, lifestyle, and physiological adaptation.
What is the biochemical role of the FOLH1 gene?
FOLH1 produces the enzyme glutamate carboxypeptidase II, which breaks down N-acetyl-aspartyl-glutamate (NAAG) into N-acetylaspartate (NAA) and glutamate. This process participates in excitatory neurotransmitter signaling, neural metabolism, and cellular nutrient homeostasis.
Is rs55729124 linked to any clinical diseases or medical conditions?
Currently, rs55729124 is not classified as a pathogenic mutation for inherited diseases in clinical repositories such as ClinVar. It is primarily studied as a common intronic variant influencing continuous biochemical traits such as blood metabolite concentrations.
Should I modify my exercise regimen or diet based on this genetic result?
There is no clinical or athletic guideline recommending specific dietary or training adjustments based on rs55729124. Any significant changes to your physical training, nutrition, or supplement routine should be made in consultation with a licensed healthcare provider or sports dietitian.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs55729124?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29